Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice

Diabetes

Volumn 62, Issue 6, 2013, Pages 1957-1969

  Abe, Tomoki ^a   Hirasaka, Katsuya ^a   Kagawa, Sachiko ^a   Kohno, Shohei ^a   Ochi, Arisa ^a   Utsunomiya, Kenro ^a   Sakai, Atsuko ^a   Ohno, Ayako ^a   Teshima Kondo, Shigetada ^a   Okumura, Yuushi ^a   Oarada, Motoko ^b   Maekawa, Yoichi ^a   Terao, Junji ^a   Mills, Edward M ^c   Nikawa, Takeshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASITAS B CELL LYMPHOMA B UBIQUITIN LIGASE; ERITORAN; GLUCOSE; INTERLEUKIN 6; SATURATED FATTY ACID; TOLL LIKE RECEPTOR 4; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OBESITY; PERITONEUM MACROPHAGE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; MICE; MICE, KNOCKOUT; NF-KAPPA B; OBESITY; PROTO-ONCOGENE PROTEINS C-CBL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878253581     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0677     Document Type: Article

References (41)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-867 (Pubitemid 46024993)
2. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91 (Pubitemid 23036092)
4. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808 (Pubitemid 38063703)
5. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830 (Pubitemid 38063705)
6. de Luca C, Olefsky JM. Stressed out about obesity and insulin resistance. Nat Med 2006;12:41-42; discussion 42
7. Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S. Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene. Oncogene 1995;10:2367-2377
8. Liu YC, Gu H. Cbl and Cbl-b in T-cell regulation. Trends Immunol 2002;23:140-143 (Pubitemid 34178296)
9. Hirasaka K, Kohno S, Goto J, et al. Deficiency of cbl-b gene enhances in filtration and activation of macrophages in adipose tissue and causes peripheral insulin resistance in mice. Diabetes 2007;56:2511-5122.
10. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 2005;25:2062-2068 (Pubitemid 41416301)
11. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119
12. Lee JY, Ye J, Gao Z, et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003;278:37041-37051 (Pubitemid 37175218)
13. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006;116:3015-3025 (Pubitemid 44684486)
14. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007;56:1986-1998. (Pubitemid 47195825)
15. Bachmaier K, Toya S, Gao X, et al. E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury. Nat Med 2007;13:920-926 (Pubitemid 47222038)
16. Chiang YJ, Kole HK, Brown K, et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 2000;403:216-220 (Pubitemid 30050967)
17. Nakao R, Hirasaka K, Goto J, et al. Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading. Mol Cell Biol 2009;29:4798-4811
18. Kim HM, Park BS, Kim JI, et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007;130:906-917 (Pubitemid 47332573)
19. Saberi M, Woods NB, de Luca C, et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009;10:419-429
20. Hirasaka K, Nikawa T, Yuge L, et al. Clinorotation prevents differentiation of rat myoblastic L6 cells in association with reduced NF-kappa B signaling. Biochim Biophys Acta 2005;1743:130-140
21. Ogawa T, Furochi H, Mameoka M, et al. Ubiquitin ligase gene expression in healthy volunteers with 20-day bedrest. Muscle Nerve 2006;34:463-469 (Pubitemid 44506715)
22. Noble JE, Bailey MJ. Quantitation of protein. Methods Enzymol 2009;463:73-95
23. Spayd RW, Bruschi B, Burdick BA, et al. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem 1978;24:1343-1350 (Pubitemid 8392014)
24. Shimizu S, Yasui K, Tani Y, Yamada H. Acyl-CoA oxidase from Candida tropicalis. Biochem Biophys Res Commun 1979;91:108-113 (Pubitemid 10183348)
25. Minami A, Iseki M, Kishi K, et al. Increased insulin sensitivity and hypoinsulinemia in APS knockout mice. Diabetes 2003;52:2657-2665 (Pubitemid 37339694)
26. Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem 2003;278:13740-13746 (Pubitemid 36799910)
27. Solinas G, Vilcu C, Neels JG, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab 2007;6:386-397 (Pubitemid 350012000)
28. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007;27:84-91 (Pubitemid 46370478)
29. Kanarek N, Ben-Neriah Y. Regulation of NF-κB by ubiquitination and degradation of the IkBs. Immunol Rev 2012;246:77-94
30. Akashi S, Shimazu R, Ogata H, et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000;164:3471-3475 (Pubitemid 30169795)
31. Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J Biol Chem 2001;276:4872-4878
32. Gruber T, Hermann-Kleiter N, Hinterleitner R, et al. PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation. Sci Signal 2009;2:ra30
33. Qiao G, Li Z, Molinero L, et al. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol Cell Biol 2008;28:2470-2480 (Pubitemid 351429990)
34. Gustin SE, Thien CB, Langdon WY. Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells. J Immunol 2006;177:5980-5989 (Pubitemid 44628811)
35. Dikic I, Giordano S. Negative receptor signalling. Curr Opin Cell Biol 2003;15:128-135 (Pubitemid 36332186)
36. Medvedev AE, Piao W, Shoenfelt J, et al. Role of TLR4 tyrosine phosphorylation in signal transduction and endotoxin tolerance. J Biol Chem 2007;282:16042-16053 (Pubitemid 47100380)
37. Han C, Jin J, Xu S, Liu H, Li N, Cao X. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 2010;11:734-742
38. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 2010;207:245-255
39. Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 2010;107:240-245
40. Lee YS, Li P, Huh JY, et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 2011;60:2474-2483
41. Mullarkey M, Rose JR, Bristol J, et al. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist. J Pharmacol Exp Ther 2003;304:1093-1102 (Pubitemid 36254422)